Cystic Fibrosis Airways: Does Disease Stem from Faulty Stem Cells?

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2023 Sep 26

PMID 37751560

Authors

Katherine B Hisert

Eszter K Vladar

Affiliations

Soon will be listed here.

References

Taylor-Cousar J, Robinson P, Shteinberg M, Downey D . CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis. Lancet. 2023; 402(10408):1171-1184. DOI: 10.1016/S0140-6736(23)01609-4. View

Graeber S, Mall M . The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches. Lancet. 2023; 402(10408):1185-1198. DOI: 10.1016/S0140-6736(23)01608-2. View

Doudna J . The promise and challenge of therapeutic genome editing. Nature. 2020; 578(7794):229-236. PMC: 8992613. DOI: 10.1038/s41586-020-1978-5. View

Eenjes E, Tibboel D, Wijnen R, Rottier R . Lung epithelium development and airway regeneration. Front Cell Dev Biol. 2022; 10:1022457. PMC: 9589436. DOI: 10.3389/fcell.2022.1022457. View

Khedoe P, Wu X, Gosens R, Hiemstra P . Repairing damaged lungs using regenerative therapy. Curr Opin Pharmacol. 2021; 59:85-94. PMC: 9188766. DOI: 10.1016/j.coph.2021.05.002. View

Stoltz D, Meyerholz D, Welsh M . Origins of cystic fibrosis lung disease. N Engl J Med. 2015; 372(4):351-62. PMC: 4916857. DOI: 10.1056/NEJMra1300109. View

Shteinberg M, Haq I, Polineni D, Davies J . Cystic fibrosis. Lancet. 2021; 397(10290):2195-2211. DOI: 10.1016/S0140-6736(20)32542-3. View

Adam D, Roux-Delrieu J, Luczka E, Bonnomet A, Lesage J, Merol J . Cystic fibrosis airway epithelium remodelling: involvement of inflammation. J Pathol. 2014; 235(3):408-19. DOI: 10.1002/path.4471. View

Lopez A, Daly C, Vega-Hernandez G, MacGregor G, Rubin J . Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. J Cyst Fibros. 2023; 22(4):607-614. DOI: 10.1016/j.jcf.2023.02.004. View

10.

King N, Suzuki S, Barilla C, Hawkins F, Randell S, Reynolds S . Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis. Hum Gene Ther. 2020; 31(17-18):956-972. PMC: 7495916. DOI: 10.1089/hum.2020.160. View

11.

Ghigo A, Prono G, Riccardi E, De Rose V . Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches. Int J Mol Sci. 2021; 22(4). PMC: 7920244. DOI: 10.3390/ijms22041952. View

12.

Wang S, Niroula S, Hoffman A, Khorrami M, Khorrami M, Yuan F . Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators. Am J Respir Crit Care Med. 2023; 208(9):930-943. PMC: 10870857. DOI: 10.1164/rccm.202305-0818OC. View

13.

Piorunek T, Marszalek A, Biczysko W, Gozdzik J, Cofta S, Seget M . Correlation between the stage of cystic fibrosis and the level of morphological changes in adult patients. J Physiol Pharmacol. 2009; 59 Suppl 6:565-72. View

14.

Hisert K, Birket S, Clancy J, Downey D, Engelhardt J, Fajac I . Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy. Lancet Respir Med. 2023; 11(10):916-931. DOI: 10.1016/S2213-2600(23)00324-7. View

15.

Rao W, Wang S, Duleba M, Niroula S, Goller K, Xie J . Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis. Cell. 2020; 181(4):848-864.e18. PMC: 7294989. DOI: 10.1016/j.cell.2020.03.047. View